SPECIAL NOTICE TO ALL LICENSEES FROM SBOD
ACT 124 OF 2016 – INITIAL TRAINING AND CONTINUING EDUCATION IN PAIN MANAGEMENT, ADDICTION AND PRESCRIBING AND DISPENSING
PRACTICES FOR OPIOIDS
The State Board of Dentistry (Board), in conjunction with the Department of Health, is providing advance notice to all licensees that are considered “prescribers” or “dispensers” under section 3 of the Achieving Better Care by Monitoring All Prescriptions Program (ABC-MAP) Act (35 P.S. § 872.3), as amended, that EFFECTIVE JANUARY 1, 2017, all licensees applying for the renewal of a license issued by the Board that are considered prescribers or dispensers under the ABC-MAP Act shall be required to complete at least 2 hours of Board-approved continuing education in pain management, identification of addiction or the practices of prescribing or dispensing of opioids as a condition of renewal.
Please note that the continuing education requirements of Act 124 will NOT be necessary in order to renew your license in 2017. However, you will be required to complete at least 2 hours of Board-approved continuing education in pain management, identification of addiction or the practices of prescribing or dispensing of opioids as a condition of renewal in 2019.
More information regarding this requirement will be posted on the Board’s website when it is available.
Act 124 may be reviewed at the following link:
IMPORTANT UPDATE ON NEW ACT 124 CE REQUIREMENT
PDA has obtained clarification from the Department of State's Bureau of Professional and Occupational Affairs (BPOA) about exemptions in Act 124 for health care providers who do not prescribe controlled substances.
BPOA confirmed that there are two exemptions for licensees:
Licensees who are exempt from the federal Drug Enforcement Agency's (DEA) requirements for a registration number.
Licensees who do not use the registration number of another person or entity, as permitted by law, to prescribe controlled substances in any manner.
The continuing education (CE) requirement does apply to all licensees who have a current DEA registration or use another DEA number (as permitted by law) to prescribe controlled substances. Please note that the CE requirement is not required for license renewal in 2017 but is a condition of renewal in 2019. Please contact our government relations staff at (800) 223-0016 or email@example.com, with any questions or concerns.
The Prescription Drug Monitoring Program Office (PDMP Office) developed a series of seven modules, each for one hour of credit, available at:
Modules 3–7 can be used to meet the Act 124 of 2016 opioid education requirements and dentists need to complete at least two modules.